These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 27633081

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Featured article: Structure moderation of gut microbiota in liraglutide-treated diabetic male rats.
    Zhang Q, Xiao X, Zheng J, Li M, Yu M, Ping F, Wang T, Wang X.
    Exp Biol Med (Maywood); 2018 Jan; 243(1):34-44. PubMed ID: 29171288
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Novel GLP-1/GLP-2 co-agonists display marked effects on gut volume and improves glycemic control in mice.
    Wismann P, Pedersen SL, Hansen G, Mannerstedt K, Pedersen PJ, Jeppesen PB, Vrang N, Fosgerau K, Jelsing J.
    Physiol Behav; 2018 Aug 01; 192():72-81. PubMed ID: 29540315
    [Abstract] [Full Text] [Related]

  • 5. Effects of metformin, saxagliptin and repaglinide on gut microbiota in high-fat diet/streptozocin-induced type 2 diabetic mice.
    Tang Y, Yan M, Fang Z, Jin S, Xu T.
    BMJ Open Diabetes Res Care; 2024 May 06; 12(3):. PubMed ID: 38719505
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Liraglutide alleviates experimental diabetic cardiomyopathy in a PDH-dependent manner.
    Chan JSF, Greenwell AA, Saed CT, Stenlund MJ, Mangra-Bala IA, Tabatabaei Dakhili SA, Yang K, Ferrari SR, Eaton F, Gopal K, Ussher JR.
    J Endocrinol; 2024 Aug 01; 262(2):. PubMed ID: 38860519
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Liraglutide pharmacotherapy reduces body weight and improves glycaemic control in juvenile obese/hyperglycaemic male and female rats.
    Liberini CG, Lhamo R, Ghidewon M, Ling T, Juntereal N, Chen J, Cao A, Stein LM, Hayes MR.
    Diabetes Obes Metab; 2019 Apr 01; 21(4):866-875. PubMed ID: 30456866
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes.
    Gangadharan Komala M, Gross S, Zaky A, Pollock C, Panchapakesan U.
    Nephrology (Carlton); 2016 May 01; 21(5):423-31. PubMed ID: 26375854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.